leadf
logo-loader
viewSareum Holdings PLC
(
AIM:SARFRA:RYH
)

Sareum Holdings raises over a £1mln to advance preclinical work on its TYK2/JAK1 drugs

Sareum Holdings PLC's (LON:SAR) Tim Mitchell caught up with Proactive London's Andrew Scott following the news it's raised just over £1mln to advance the preclinincal work on its TYK2/JAK1 drugs SDC-1801 and SDC-1802.

Mitchell says they're exploring the potential benefit of the TYK2/JAK1 inhibitors against coronavirus (COVID-19) as well as in cancer and autoimmune diseases.

Preparatory work is being made to advance candidates towards human trials.

Quick facts: Sareum Holdings PLC

Follow
AIM:SAR

Price: 6.6 GBX

Market Cap: £222.14 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Hochschild Mining reveals 'profitable' PEA on its heavy rare earths project...

Hochschild Mining Head of Investor Relations Charles Gordon joined Proactive New York to discuss the Peru-based gold and silver miner's recent developments within its heavy rare earths project, recently renamed Aclara. Gordon says the group recently revealed a preliminary economic assessment...

12 hours, 30 minutes ago

2 min read